Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 18 of the 18 references it cites were found in a registry or an index.

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

Abstract

Background Sibutramine is a tertiary amine that has been shown to induce dose-dependent weight loss and to enhance the effects of a low-calorie diet for up to a year. We did a randomised, double-blind trial to assess the usefulness of sibutramine in maintaining substantial weight loss over 2 years. Methods Eight European centres recruited 605 obese patients (body-mass index 30-45 kg/m2) for a 6-month period of weight loss with sibutramine (10 mg/day) and an individualised 600 kcal/day deficit programme based on measured resting metabolic rates. 467 (77%) patients with more than 5% weight loss were then randomly assigned 10 mg/day sibutramine (n=352) or placebo (n=115) for a further 18 months. Sibutramine was increased up to 20 mg/day if weight regain occurred. The primary outcome measure was the number of patients at year 2 maintaining at least 80% of the weight lost between baseline and month 6. Secondary outcomes included changes in uric acid concentrations and glycaemic and lipid variables. Analysis was by intention to treat. Findings 148 (42%) individuals in the sibutramine group and 58 (50%) in the placebo group dropped out. Of the 204 sibutramine-treated individuals who completed the trial, 89 (43%) maintained 80% or more of their original weight loss, compared with nine (16%) of the 57 individuals in the placebo group (odds ratio 4.64, p Interpretation This individualised management programme achieved weight loss in 77% of obese patients and sustained weight loss in mo…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(00)03491-7

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 18 references

Research works printed but not linked: 1

  1. Lauterbach, 2000, The impact of sibutramine on CHD: a subgroup analysis, Int J Obesity, 24, S99

Cited by

See all 818

Metadata

Authors
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V.
Affiliations
  • Luton and Dunstable Hospital (GB)
  • Hvidovre Hospital (DK)
  • Royal London Hospital (GB)
  • Integrated Cardio Metabolic Centre (SE)
  • Antwerp University Hospital (BE)
Corresponding author
James, W Philip T
Venue
The Lancet
Publisher
Elsevier BV
Published
2000-12
Volume
356
Issue
9248
Pages
2119-2125
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2151048121
Cited by
817
References
18
Citations by year
2026: 6 · 2025: 6 · 2024: 7 · 2023: 3 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 4 · 2016: 12 · 2015: 10 · 2014: 10 · 2013: 16 · 2012: 28
FWCI
32.78
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
sibutramine, weight loss maintenance, obesity, weight regain, appetite suppressants, hypocaloric diet, triglycerides, HDL cholesterol, uric acid, blood pressure, insulin resistance, C-peptide, long-term weight management, dose titration, adverse effects, body mass index, glycemic control, lipid profile
MeSH terms
Adolescent, Adult, Aged, Appetite Depressants, Cyclobutanes, Diet, Reducing, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Male, Metabolism, Middle Aged, Obesity, Weight Loss, Logistic Models, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of sibutramine on weight maintenance after weight loss: a randomised trial. https://app.cochat.ai/papers/10.1016/s0140-6736(00)03491-7
The paper
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000). Effect of sibutramine on weight maintenance after weight loss: a randomised trial. The Lancet. https://doi.org/10.1016/s0140-6736(00)03491-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.